Possibilities of modern biomarkers for assessing the risk of developing ventricular tachyarrhythmias and sudden cardiac death in patients with chronic heart failure
Current biomarkers allow diagnosing a wide array of pathological processes and evaluating effects of therapies and prognosis for cardiological patients. This review focuses on a possibility of using N-terminal pro-brain natriuretic peptide (NT-proBNP), soluble suppressor of tumorigenicity 2 (sST2),...
Saved in:
Published in | Kardiologiia Vol. 60; no. 4; p. 101 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | Russian |
Published |
Russia (Federation)
04.05.2020
|
Online Access | Get more information |
Cover
Loading…
Summary: | Current biomarkers allow diagnosing a wide array of pathological processes and evaluating effects of therapies and prognosis for cardiological patients. This review focuses on a possibility of using N-terminal pro-brain natriuretic peptide (NT-proBNP), soluble suppressor of tumorigenicity 2 (sST2), galectin-3, and other biomarkers in patients with chronic heart failure for evaluating the risk of life-threatening ventricular tachyarrhythmias and sudden cardiac death. |
---|---|
ISSN: | 0022-9040 |
DOI: | 10.18087/cardio.2020.4.n487 |